Q1 Earnings Forecast for BMRN Issued By William Blair
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) – Equities researchers at William Blair issued their Q1 2026 EPS estimates for BioMarin Pharmaceutical in a note issued to investors on Thursday, February 20th. William Blair analyst S. Corwin expects that the biotechnology company will post earnings of $0.93 per share for the quarter. William Blair has […]
